510 related articles for article (PubMed ID: 30368976)
1. Generation of PDX-1 mutant porcine blastocysts by introducing CRISPR/Cas9-system into porcine zygotes via electroporation.
Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
Anim Sci J; 2019 Jan; 90(1):55-61. PubMed ID: 30368976
[TBL] [Abstract][Full Text] [Related]
2. Efficient generation of GGTA1-deficient pigs by electroporation of the CRISPR/Cas9 system into in vitro-fertilized zygotes.
Tanihara F; Hirata M; Nguyen NT; Sawamoto O; Kikuchi T; Doi M; Otoi T
BMC Biotechnol; 2020 Aug; 20(1):40. PubMed ID: 32811500
[TBL] [Abstract][Full Text] [Related]
3. Suppression of mosaic mutation by co-delivery of CRISPR associated protein 9 and three-prime repair exonuclease 2 into porcine zygotes via electroporation.
Yamashita S; Kogasaka Y; Hiradate Y; Tanemura K; Sendai Y
J Reprod Dev; 2020 Feb; 66(1):41-48. PubMed ID: 31761839
[TBL] [Abstract][Full Text] [Related]
4. Genome mutation after introduction of the gene editing by electroporation of Cas9 protein (GEEP) system in matured oocytes and putative zygotes.
Hirata M; Tanihara F; Wittayarat M; Hirano T; Nguyen NT; Le QA; Namula Z; Nii M; Otoi T
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):237-242. PubMed ID: 30820813
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of multiple gene targeting in porcine embryos by the CRISPR/Cas9 system using electroporation.
Hirata M; Wittayarat M; Namula Z; Le QA; Lin Q; Nguyen NT; Takebayashi K; Sato Y; Tanihara F; Otoi T
Mol Biol Rep; 2020 Jul; 47(7):5073-5079. PubMed ID: 32519310
[TBL] [Abstract][Full Text] [Related]
6. Effects of voltage strength during electroporation on the development and quality of in vitro-produced porcine embryos.
Nishio K; Tanihara F; Nguyen TV; Kunihara T; Nii M; Hirata M; Takemoto T; Otoi T
Reprod Domest Anim; 2018 Apr; 53(2):313-318. PubMed ID: 29135047
[TBL] [Abstract][Full Text] [Related]
7. GEEP Method: An Optimized Electroporation-Mediated Gene Editing Approach for Establishment of Knockout Pig Lines.
Tanihara F; Hirata M; Otoi T
Methods Mol Biol; 2023; 2637():293-300. PubMed ID: 36773155
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
9. Effects of electroporation treatment using different concentrations of Cas9 protein with gRNA targeting Myostatin (MSTN) genes on the development and gene editing of porcine zygotes.
Le QA; Hirata M; Nguyen NT; Takebayashi K; Wittayarat M; Sato Y; Namula Z; Nii M; Tanihara F; Otoi T
Anim Sci J; 2020; 91(1):e13386. PubMed ID: 32512638
[TBL] [Abstract][Full Text] [Related]
10. Generation of
Tanihara F; Hirata M; Nguyen NT; Le QA; Wittayarat M; Fahrudin M; Hirano T; Otoi T
Anim Biotechnol; 2021 Apr; 32(2):147-154. PubMed ID: 31558095
[TBL] [Abstract][Full Text] [Related]
11. One-step genome editing of porcine zygotes through the electroporation of a CRISPR/Cas9 system with two guide RNAs.
Hirata M; Wittayarat M; Tanihara F; Sato Y; Namula Z; Le QA; Lin Q; Takebayashi K; Otoi T
In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):614-621. PubMed ID: 32978715
[TBL] [Abstract][Full Text] [Related]
12. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
[TBL] [Abstract][Full Text] [Related]
13. Electroporation-mediated genome editing in vitrified/warmed porcine zygotes obtained in vitro.
Haraguchi S; Dang-Nguyen TQ; Kikuchi K; Somfai T
Mol Reprod Dev; 2024 Jan; 91(1):e23712. PubMed ID: 37882473
[TBL] [Abstract][Full Text] [Related]
14. Zona pellucida treatment before CRISPR/Cas9-mediated genome editing of porcine zygotes.
Namula Z; Hirata M; Le QA; Lin Q; Takebayashi K; Yoshimura N; Tanihara F; Thongkittidilok C; Otoi T
Vet Med Sci; 2022 Jan; 8(1):164-169. PubMed ID: 34674375
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of introducing the CRISPR/Cas9 system by microinjection and electroporation into porcine embryos at different stages.
Le QA; Tanihara F; Wittayarat M; Namula Z; Sato Y; Lin Q; Takebayashi K; Hirata M; Otoi T
BMC Res Notes; 2021 Jan; 14(1):7. PubMed ID: 33407863
[TBL] [Abstract][Full Text] [Related]
16. Gene editing in porcine embryos using a combination of electroporation and transfection methods.
Takebayashi K; Wittayarat M; Lin Q; Hirata M; Yoshimura N; Torigoe N; Nagahara M; Do LTK; Tanihara F; Otoi T
Reprod Domest Anim; 2022 Oct; 57(10):1136-1142. PubMed ID: 35699358
[TBL] [Abstract][Full Text] [Related]
17. Timing and duration of lipofection-mediated CRISPR/Cas9 delivery into porcine zygotes affect gene-editing events.
Lin Q; Le QA; Takebayashi K; Thongkittidilok C; Wittayarat M; Hirata M; Tanihara F; Otoi T
BMC Res Notes; 2021 Oct; 14(1):389. PubMed ID: 34627381
[TBL] [Abstract][Full Text] [Related]
18. Introduction of a point mutation in the KRAS gene of in vitro fertilized porcine zygotes via electroporation of the CRISPR/Cas9 system with single-stranded oligodeoxynucleotides.
Wittayarat M; Hirata M; Namula Z; Sato Y; Nguyen NT; Le QA; Lin Q; Takebayashi K; Tanihara F; Otoi T
Anim Sci J; 2021; 92(1):e13534. PubMed ID: 33638256
[TBL] [Abstract][Full Text] [Related]
19. Electroporation of Cas9 protein/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse.
Hashimoto M; Yamashita Y; Takemoto T
Dev Biol; 2016 Oct; 418(1):1-9. PubMed ID: 27474397
[TBL] [Abstract][Full Text] [Related]
20. Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation.
Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
PLoS One; 2018; 13(10):e0206360. PubMed ID: 30352075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]